BSX
Boston Scientific CorporationBoston Scientific Corporation operates in the Surgical & Medical Instruments & Apparatus industry.
The numbers · FY2025, filed
SEC EDGARAll filed figures
Snapshot
SEC EDGAR · FY 2025-12-31Revenue by fiscal year
Operating leverage — margins
Financials, annual · income and cash flowSEC EDGAR · open ▸
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $11.9B | $12.7B | $14.2B | $16.7B | $20.1B |
| Gross Profit | $8.2B | $8.7B | $9.9B | $11.5B | $13.9B |
| Operating Income | $1.2B | $1.6B | $2.3B | $2.6B | $3.6B |
| Net Income | $1.0B | $698.0M | $1.6B | $1.8B | $2.9B |
| Diluted EPS | $0.69 | $0.45 | $1.07 | $1.25 | $1.94 |
| Operating Cash Flow | $1.9B | $1.5B | $2.5B | $3.4B | $4.5B |
| Free Cash Flow | $1.3B | $938.0M | $1.8B | $2.6B | $3.7B |
Same industry
In the screener →BSX story timeline
Company updates and connected market context, with the dated price move attached.
Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.
A cyberattack disrupted Boston Scientific’s guidance despite no reported shortfall in demand or device performance. The setup shifts attention from operating momentum to the duration, cost and disclosure risk of the incident.
Boston Scientific ‘Unlikely to Meet’ Earnings Guidance After Cyberattack. Stock Falls.
Boston Scientific says it is unlikely to meet earnings guidance after a cyberattack, sending BSX shares lower. The immediate setup shifts toward estimate risk and the timing of operational recovery, with the next company update more important than the initial stock reaction.
Boston Scientific reports cybersecurity incident affecting operations, shares fall
Boston Scientific reported a cybersecurity incident affecting operations, sending BSX shares lower. The setup shifts attention to the duration of disruption, remediation costs and any impact on the company’s strong revenue trajectory.
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.